vs
NEOGENOMICS INC（NEO）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
ROGERS CORP的季度营收约是NEOGENOMICS INC的1.1倍（$200.5M vs $186.7M），ROGERS CORP净利率更高（2.2% vs -57.9%，领先60.1%），NEOGENOMICS INC同比增速更快（11.1% vs 5.2%），过去两年NEOGENOMICS INC的营收复合增速更高（6.5% vs -3.3%）
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
NEO vs ROG — 直观对比
营收规模更大
ROG
是对方的1.1倍
$186.7M
营收增速更快
NEO
高出5.8%
5.2%
净利率更高
ROG
高出60.1%
-57.9%
两年增速更快
NEO
近两年复合增速
-3.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $186.7M | $200.5M |
| 净利润 | $-108.0M | $4.5M |
| 毛利率 | 43.3% | 32.2% |
| 营业利润率 | — | — |
| 净利率 | -57.9% | 2.2% |
| 营收同比 | 11.1% | 5.2% |
| 净利润同比 | 42.0% | 421.4% |
| 每股收益（稀释后） | $-0.13 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEOROG
| Q1 26 | $186.7M | $200.5M | ||
| Q4 25 | $190.2M | $201.5M | ||
| Q3 25 | $187.8M | $216.0M | ||
| Q2 25 | $181.3M | $202.8M | ||
| Q1 25 | $168.0M | $190.5M | ||
| Q4 24 | $172.0M | $192.2M | ||
| Q3 24 | $167.8M | $210.3M | ||
| Q2 24 | $164.5M | $214.2M |
净利润NEOROG
| Q1 26 | $-108.0M | $4.5M | ||
| Q4 25 | — | $4.6M | ||
| Q3 25 | $-27.1M | $8.6M | ||
| Q2 25 | $-45.1M | $-73.6M | ||
| Q1 25 | $-25.9M | $-1.4M | ||
| Q4 24 | — | $-500.0K | ||
| Q3 24 | $-17.7M | $10.7M | ||
| Q2 24 | $-18.6M | $8.1M |
毛利率NEOROG
| Q1 26 | 43.3% | 32.2% | ||
| Q4 25 | 43.8% | 31.5% | ||
| Q3 25 | 42.8% | 33.5% | ||
| Q2 25 | 42.6% | 31.6% | ||
| Q1 25 | 43.6% | 29.9% | ||
| Q4 24 | 44.9% | 32.1% | ||
| Q3 24 | 44.6% | 35.2% | ||
| Q2 24 | 44.1% | 34.1% |
营业利润率NEOROG
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | 3.5% | ||
| Q3 25 | -14.4% | 7.3% | ||
| Q2 25 | -26.3% | -33.3% | ||
| Q1 25 | -16.6% | -0.2% | ||
| Q4 24 | -10.7% | -6.6% | ||
| Q3 24 | -12.6% | 6.9% | ||
| Q2 24 | -13.3% | 5.3% |
净利率NEOROG
| Q1 26 | -57.9% | 2.2% | ||
| Q4 25 | — | 2.3% | ||
| Q3 25 | -14.4% | 4.0% | ||
| Q2 25 | -24.9% | -36.3% | ||
| Q1 25 | -15.4% | -0.7% | ||
| Q4 24 | — | -0.3% | ||
| Q3 24 | -10.5% | 5.1% | ||
| Q2 24 | -11.3% | 3.8% |
每股收益（稀释后）NEOROG
| Q1 26 | $-0.13 | $0.25 | ||
| Q4 25 | — | $0.20 | ||
| Q3 25 | — | $0.48 | ||
| Q2 25 | — | $-4.00 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | — | $0.58 | ||
| Q2 24 | — | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.1M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $828.8M | $1.2B |
| 总资产 | $1.3B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEOROG
| Q1 26 | $146.1M | $195.8M | ||
| Q4 25 | $159.6M | $197.0M | ||
| Q3 25 | $164.1M | $167.8M | ||
| Q2 25 | $154.7M | $157.2M | ||
| Q1 25 | $346.2M | $175.6M | ||
| Q4 24 | $367.0M | $159.8M | ||
| Q3 24 | $362.0M | $146.4M | ||
| Q2 24 | $355.1M | $119.9M |
总债务NEOROG
| Q1 26 | — | — | ||
| Q4 25 | $341.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $541.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NEOROG
| Q1 26 | $828.8M | $1.2B | ||
| Q4 25 | $836.6M | $1.2B | ||
| Q3 25 | $838.3M | $1.2B | ||
| Q2 25 | $854.0M | $1.2B | ||
| Q1 25 | $888.3M | $1.3B | ||
| Q4 24 | $902.3M | $1.3B | ||
| Q3 24 | $908.2M | $1.3B | ||
| Q2 24 | $915.9M | $1.3B |
总资产NEOROG
| Q1 26 | $1.3B | $1.4B | ||
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.4B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.6B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.6B | $1.5B |
负债/权益比NEOROG
| Q1 26 | — | — | ||
| Q4 25 | 0.41× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.1M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | — | $1.1M |
| 自由现金流率自由现金流/营收 | — | 0.5% |
| 资本支出强度资本支出/营收 | — | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | — | $70.1M |
8季度趋势，按日历期对齐
经营现金流NEOROG
| Q1 26 | $-8.1M | $5.8M | ||
| Q4 25 | $1.3M | $46.9M | ||
| Q3 25 | $8.9M | $28.9M | ||
| Q2 25 | $20.3M | $13.7M | ||
| Q1 25 | $-25.3M | $11.7M | ||
| Q4 24 | $9.8M | $33.7M | ||
| Q3 24 | $9.2M | $42.4M | ||
| Q2 24 | $13.9M | $22.9M |
自由现金流NEOROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $-6.5M | $42.2M | ||
| Q3 25 | $570.0K | $21.2M | ||
| Q2 25 | $14.0M | $5.6M | ||
| Q1 25 | $-29.8M | $2.1M | ||
| Q4 24 | $-1.8M | $18.3M | ||
| Q3 24 | $-1.6M | $25.2M | ||
| Q2 24 | $814.0K | $8.8M |
自由现金流率NEOROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | -3.4% | 20.9% | ||
| Q3 25 | 0.3% | 9.8% | ||
| Q2 25 | 7.7% | 2.8% | ||
| Q1 25 | -17.8% | 1.1% | ||
| Q4 24 | -1.0% | 9.5% | ||
| Q3 24 | -0.9% | 12.0% | ||
| Q2 24 | 0.5% | 4.1% |
资本支出强度NEOROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 4.1% | 2.3% | ||
| Q3 25 | 4.4% | 3.6% | ||
| Q2 25 | 3.5% | 4.0% | ||
| Q1 25 | 2.7% | 5.0% | ||
| Q4 24 | 6.7% | 8.0% | ||
| Q3 24 | 6.4% | 8.2% | ||
| Q2 24 | 8.0% | 6.6% |
现金转化率NEOROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
